THE establishment and maintenance of telomere length equilibrium is essential for cell survival. Yeast cells that fail to maintain telomeres undergo senescence ([@bib41]), which is mediated by the DNA damage response to short telomeres ([@bib17]; [@bib32]). In primary human cell cultures, short telomeres initiate replicative senescence ([@bib26]; [@bib5]) by signaling DNA damage ([@bib14]). This cellular response to short telomeres underlies a spectrum of human diseases that includes bone marrow failure, pulmonary fibrosis, and immune senescence, collectively called the telomere syndromes ([@bib1]). Conversely, inappropriate telomere maintenance allows the survival of cancer cells ([@bib33]), and mutations that increase telomerase expression predispose people to melanoma ([@bib29]; [@bib31]) and other cancers ([@bib27]). To fully address the role of telomeres in disease, a detailed mechanistic understanding of telomere length maintenance is critical.

Telomere sequence DNA repeats are bound by a set of proteins that mediate two essential functions: first, to protect the ends from degradation, recombination, and initiation of a damage response and second, to regulate telomere elongation by telomerase. Telomerase adds telomere repeats to chromosome ends to counterbalance the shortening that occurs during replication ([@bib24]), but this addition must be regulated. While the telomere-binding proteins in *Saccharomyces cerevisiae* and mammalian cells are not conserved in sequence, the function of telomere binding proteins limiting telomere elongation is conserved across eukaryotes ([@bib56]). In yeast, deletion of the genes encoding the telomere binding proteins [Rif1](http://www.yeastgenome.org/locus/S000000479/overview) and [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) leads to telomere elongation ([@bib25]; [@bib62]). In mammals, removal of telomere binding proteins from the telomere, including TRF1, TRF2, and POT1, also results in telomere elongation ([@bib58]; [@bib55]; [@bib12]; [@bib59]; [@bib48]). The conservation of this negative length regulation pathway highlights the importance of understanding the mechanism that limits telomere elongation.

In yeast, the [Rap1](http://www.yeastgenome.org/locus/S000005160/overview)/[Rif1](http://www.yeastgenome.org/locus/S000000479/overview)/[Rif2](http://www.yeastgenome.org/locus/S000004445/overview) protein complex binds to the double-stranded telomere repeats ([@bib39]; [@bib25]; [@bib62]), and the [Cdc13](http://www.yeastgenome.org/locus/S000002379/overview) complex ([@bib37]; [@bib47]) binds to the single-stranded G-rich 3′ overhang. [Cdc13](http://www.yeastgenome.org/locus/S000002379/overview) interacts with [Stn1](http://www.yeastgenome.org/locus/S000002489/overview) and [Ten1](http://www.yeastgenome.org/locus/S000004000/overview) ([@bib21], [@bib22]) to form a RPA (Replication Protein A)-like trimeric complex ([@bib19]) that regulates telomere elongation. In addition to these DNA binding complexes, there are other proteins that associate with telomeres and help regulate both end protection and telomere length. These include a number of proteins that are involved in DNA break repair and checkpoint signaling, such as the MRX ([Mre11](http://www.yeastgenome.org/locus/S000004837/overview), [Rad50](http://www.yeastgenome.org/locus/S000005194/overview), [Xrs2](http://www.yeastgenome.org/locus/S000002777/overview)) complex, the [Ku70](http://www.yeastgenome.org/locus/S000004897/overview)/[80](http://www.yeastgenome.org/locus/S000004712/overview) heterodimer, and the [Tel1](http://www.yeastgenome.org/locus/S000000184/overview)/ATM protein kinase ([@bib52]; [@bib61]).

In yeast, [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) recruits the [Rif1](http://www.yeastgenome.org/locus/S000000479/overview) and [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) proteins that limit telomere elongation ([@bib25]; [@bib43]; [@bib62]; [@bib35]). Deletion of either *[RIF1](http://www.yeastgenome.org/locus/S000000479/overview)* or *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* results in long telomeres and deletion of the two together has an additive effect, resulting in very long telomeres. [Rif1](http://www.yeastgenome.org/locus/S000000479/overview) and [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) bind to the C-terminal domain of [Rap1](http://www.yeastgenome.org/locus/S000005160/overview), and deletion of this domain results in very long telomeres, similar to the *[rif1](http://www.yeastgenome.org/locus/S000000479/overview)Δ [rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* double mutant ([@bib62]). This additive effect suggests these two proteins might use different mechanisms to limit telomere elongation.

A protein-counting model for negative regulation of telomere elongation was first proposed in yeast ([@bib43]). This model suggests the more [Rap1](http://www.yeastgenome.org/locus/S000005160/overview)/[Rif1](http://www.yeastgenome.org/locus/S000000479/overview)/[Rif2](http://www.yeastgenome.org/locus/S000004445/overview) complexes that are bound along the telomere, the larger the repressive effect of telomere elongation. Thus, short telomeres have fewer repressive proteins bound and are more frequently elongated, whereas on longer telomeres, the [Rap1](http://www.yeastgenome.org/locus/S000005160/overview)/[Rif1](http://www.yeastgenome.org/locus/S000000479/overview)/[Rif2](http://www.yeastgenome.org/locus/S000004445/overview) exerts a strong repressive effect so these telomeres are elongated less frequently. Recruiting [Rif1](http://www.yeastgenome.org/locus/S000000479/overview) and [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) to the telomere by fusion to other DNA binding domains also limits telomere elongation, indicating it is [Rif1](http://www.yeastgenome.org/locus/S000000479/overview) and [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) function, rather than [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) *per se*, that limits telomere elongation ([@bib35]). The interplay of the preferential elongation of short telomeres ([@bib4]) and limiting the extent of elongation at long telomeres is thought to mediate the telomere length equilibrium.

The molecular mechanism by which [Rif1](http://www.yeastgenome.org/locus/S000000479/overview) and [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) limit telomere elongation remains unclear. In mammalian cells, [Rif1](http://www.yeastgenome.org/locus/S000000479/overview) was shown to play a role in replication fork progression ([@bib9]) and in the timing of replication origin firing ([@bib13]; [@bib63]). This role in regulating origin firing is conserved in yeast ([@bib36]; [@bib45]; [@bib49]) where [Rif1](http://www.yeastgenome.org/locus/S000000479/overview) also functions in regulating resection of double-strand breaks and DNA recombination ([@bib15]; [@bib18]; [@bib64]).

Like *[RIF1](http://www.yeastgenome.org/locus/S000000479/overview)*, the *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* gene in yeast also plays a role in protecting chromosome ends from resection. *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* mutants show increased single-stranded DNA at telomeres ([@bib6]) that requires the MRX complex and its regulator, the [Tel1](http://www.yeastgenome.org/locus/S000000184/overview) kinase ([@bib7]). Moreover, *in vitro* experiments have suggested that [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) binds directly to the C-terminal region of [Xrs2](http://www.yeastgenome.org/locus/S000002777/overview) and regulates telomere length through the [Tel1](http://www.yeastgenome.org/locus/S000000184/overview) pathway ([@bib28]). [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) also protects telomeres from chromosome fusion events ([@bib16]), and the increased rate of senescence of telomerase mutants in the absence of *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* further supports a role for [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) in end protection ([@bib11]; [@bib2]; [@bib30]). Whether this end-protection role of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) is related to the telomere elongation phenotype of the *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* is not known.

The [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) protein structure was recently determined both alone and in complex with the C-terminal region of [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) ([@bib51]). This structure revealed two different areas of contact between [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) and [Rap1](http://www.yeastgenome.org/locus/S000005160/overview). The authors propose a Velcro model of interlocking protein interactions between [Rap1](http://www.yeastgenome.org/locus/S000005160/overview), [Rif1](http://www.yeastgenome.org/locus/S000000479/overview), and [Rif2](http://www.yeastgenome.org/locus/S000004445/overview), which generate a chromatin scaffold that limits telomere elongation.

To more clearly define the molecular functions of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview), we carried out a mutagenesis screen across the entire *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* coding region. We describe here the identification of a domain in the N terminus that blocks telomere elongation by telomerase. Furthermore, mutation of a single amino acid in this domain mimics telomere lengthening seen in *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ*, suggesting that it is a critical residue for *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* function.

Materials and Methods {#s1}
=====================

Construction of plasmids and yeast strains {#s2}
------------------------------------------

All of the *S. cerevisiae* strains (termed "yeast strains") and oligonucleotides (termed "primers") for polymerase chain reaction (PCR) and for construction of plasmids used in this study are listed in [Supporting Information](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-11.pdf), [Table S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-10.pdf), [Table S2](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-2.pdf), [Table S3](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-9.pdf), [Table S4](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-3.pdf), [Table S5](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-7.pdf), and [Table S6](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-13.pdf). All restriction enzymes used in these experiments were from New England Biolabs.

NAAIRS mutagenesis {#s3}
------------------

We scanned the entire *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* gene substituting every six codons with the sequence specifying the amino acid sequence asparagine-alanine-alanine-isoleucine-arginine-serine (NAAIRS) in continuous blocks. *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* was amplified from yeast genomic DNA using primers Rif2-up and Rif2-down by PCR and the 1.67-kb product was subcloned into pCR2.1-TOPO (Life Technologies) according to the manufacturer's instructions. *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* was then subcloned into pRS406 ([@bib53]) using *Kpn*I and *Eco*RI. This plasmid was used to generate 66 *rif2NAAIRS* mutants using a three-step PCR strategy ([@bib46]). Using the construction of NAAIRS2 as an example, the first PCR incorporated the sequence encoding the NAAIRS amino acids at positions 2--7 by amplifying the 5′ end of *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* using NAAIRS2 reverse primer, [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) forward primer, and the template p406-Rif2. In the second PCR, the anti-NAAIRS2 forward primer, [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) reverse primer, and the template p406-Rif2 were used to amplify the remaining 3′ end of *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)*, also incorporating the NAAIRS substitution at amino acids 2--7. The PCR products from reactions 1 and 2 were diluted 1:100 and used as templates for amplification in a third PCR using [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) forward primer and [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) reverse primer. This generated a full-length *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)--NAAIRS2* product that was subcloned into pCR2.1-TOPO and then inserted into pRS406 using *Kpn*I and *EcoR*I to generate pNAAIRS2. Using this approach, 66 plasmids with the NAAIRS amino acid sequences substituted for continuous blocks of six amino acids within *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* were constructed. All plasmids were confirmed by sequencing and are available upon request.

Integration of the *RIF2--NAAIRS* mutants at the *URA3* locus {#s4}
-------------------------------------------------------------

The parental diploid strain for the *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)* mutagenesis was derived from W303-1a and W303-1α strains provided by O. Aparicio (OAy1002, OAy1003) ([@bib60]). *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* was deleted by PCR-based methods as described ([@bib8]). Yeast strains containing the *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)--NAAIRS* mutations were constructed by transforming a *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)*/*[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ*::*kanMX4* diploid (CVy245) with the NAAIRS mutant plasmids cut with *Nco*I within the plasmid-borne *[URA3](http://www.yeastgenome.org/locus/S000000747/overview)*, which directs integration of the plasmid into the *[ura3](http://www.yeastgenome.org/locus/S000000747/overview)-1* locus. Transformants were selected for Ura^+^. Proper integration into the yeast chromosome was confirmed by PCR. The resulting *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)/[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ*::*kanMX4*, *[ura3](http://www.yeastgenome.org/locus/S000000747/overview)-1/[ura3](http://www.yeastgenome.org/locus/S000000747/overview)-1*::*(rif2NAAIRS-[URA3](http://www.yeastgenome.org/locus/S000000747/overview)*) strains were sporulated, dissected, and haploids of the desired genotype were grown for Southern blot analysis of telomere length. Following telomere length analysis the *rif2NAAIRS* integrant was PCR amplified from genomic DNA and sequenced to reconfirm the expected NAAIRS mutation. *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* was integrated at the *[URA3](http://www.yeastgenome.org/locus/S000000747/overview)* locus to generate the wild-type control strain. Yeast culture conditions, transformations, and dissections were performed as described ([@bib23]).

Epitope-tagged *RIF2* {#s5}
---------------------

We used two different epitope tags to determine the expression level of *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* mutants by Western analysis. We used a 13xMyc epitope to tag the NAAIRS mutants at the *[URA3](http://www.yeastgenome.org/locus/S000000747/overview)* locus and actin as a loading control. For the single amino acid mutants integrated at the *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* locus, we used a V5 epitope tag and phosphoglycerol kinase (PGK) as a loading control. We tagged *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* and specific *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)--NAAIRS* mutants integrated at the *[URA3](http://www.yeastgenome.org/locus/S000000747/overview)* locus by a one-step PCR-based method using pFA6a-13xMyc-*His3MX6* ([@bib40]) using the Myc-tag forward primer and Myc-tag reverse primer. His^+^ integrants were verified by colony PCR. The *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* single amino acid mutants at the endogenous *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* locus were tagged with V5 epitope and constructed in the *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)*-V5 epitope-tagged plasmid pHK70. The plasmid was assembled according to the protocol: "Creating Insertions or Deletions Using Overlap Extension PCR Mutagenesis" ([@bib23]). This construct was made in two steps using plasmid p406-Rif2 described above that contains the *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* coding region flanked by 245 bp of genomic sequences. The primers used for each of the steps are given in parentheses. The first step amplified the C terminus of *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* together with a glycine 8 (G8) linker (HK3, HK4), a unique *Not*I site (HK7, HK9), and V5 tag from pLenti6/UbC/V5-DEST Gateway Vector (Life Technologies) (HK5, HK6), which was cloned into p406-Rif2 cut with *Bsp*EI/*Not*I, creating pHK1. The second step used overlap extension to amplify the genomic region downstream of *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* (HK18, HK19), adjacent to the upstream region of *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* (HK20, HK15), and p406-Rif2 backbone, which included a *Kpn*I site (HK16, HK17). This step removed some of the upstream region of *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* retaining a unique *Bsr*GI site. After assembly, this product was cloned into pHK1 cut with restriction enzymes *Bsr*GI and *Kpn*I, creating pHK70. The product was sequence verified. Proper chromosomal integration of epitope-tagged *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* and *NAAIRS* mutants was confirmed by PCR.

Generation of single amino acid *rif2* mutants {#s6}
----------------------------------------------

Single amino acid changes in the N-terminal region at positions 2--49 were generated in *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* in the plasmid pHK70 according to "Protocol 3: *In Vitro* Mutagenesis Using Double-Stranded DNA Templates: Selection of Mutants with *Dpn*I" ([@bib23]). To expedite this mutagenesis, some of the point mutants (pHK28--34, pHK37--64) were made by GENEWIZ. The region of each construct containing a *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)* mutation was PCR amplified and sequenced to confirm the presence of the desired mutation. Plasmids containing the *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)* mutants were cut using *Afe*I (except where indicated otherwise) and targeted to the *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* endogenous locus in OAy1002 by recombination. In cases where the mutation created an *Afe*I site (pHK3, pHK5--27, pHK51) plasmids were digested using *Bsr*GI and integrated at the *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* locus in OAy1002. Proper integration of the *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)* mutants at the endogenous *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* locus was confirmed by PCR and verified by sequencing.

*RAP1--RIF2~60~* fusion constructs integrated at the *RAP1* locus {#s7}
-----------------------------------------------------------------

We used Gibson assembly ([@bib20]) to generate the integrating plasmid pHK35, containing the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~60~* fusion gene. The final construct, based in the pRS405 vector, contains the following elements stitched together: the C-terminal region of *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)* amplified from genomic DNA, fused to a flexible glycine 10 (G10) linker (HK89, HK98); the N-terminal 60 aa of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview), including a stop codon, from p406-Rif2 (HK97, HK94); the 250-bp *[CYC1](http://www.yeastgenome.org/locus/S000003809/overview)* terminator from p414-GALS (ATCC87344) (HK117, HK118); the *[URA3](http://www.yeastgenome.org/locus/S000000747/overview)* cassette from p406-Rif2 (HK93, HK96); and 176 bp of genomic DNA 3′ of *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)* to target to the construct to the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)* locus (HK95, HK90). The construct was sequence verified and then digested with *Sac*I*/Not*I and integrated at the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)* locus in CVy245 or HKy639. Ura^+^ integrants were verified by colony PCR, sporulated, and tetrads were analyzed. Strains with the desired genotypes were selected for Southern and Western analysis.

The shorter version of the fusion protein, [Rap1](http://www.yeastgenome.org/locus/S000005160/overview)--[Rif2](http://www.yeastgenome.org/locus/S000004445/overview)~36~, was created from pHK35 using the mutagenesis method described above for the generation of single amino acid changes removing codons 37--60 (HK121, HK123) to create pHK68. The plasmid was sequence verified, digested with *Sac*I*/Not*I, and then integrated at the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)* genomic locus in HKy639. Ura^+^ integrants were verified by PCR and diploids were sporulated to generate haploid cells of the specific genotype.

The mutant *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~60~ F8A*, *F8Y*, and *F8W* fusion genes were created using the site-directed mutagenesis method described above for the generation of single amino acid changes using pHK35 as a template. The resulting plasmids (pHK65, pHK74, and pHK73, respectively) were sequenced, and those containing the desired mutations were digested with *Sac*I*/Not*I and integrated at the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)* genomic locus. Proper integration of the [RAP1](http://www.yeastgenome.org/locus/S000005160/overview) fusion genes was verified by colony PCR and sequencing.

The *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)∆C*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~60~* fusion gene was created using Gibson assembly of two fragments: the region amplified from genomic DNA, which removes 498 bp from the end of *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)* at amino acid 662 (HK128, HK129), and the region from pHK35, which contains the glycine10 linker-RIF2~60~-*CYC1* components (HK130, HK131) that were reassembled into pHK35 cut with *Not*I/*Bgl*II, creating pHK72. After sequence verification, the fusion construct was digested with *Not*I/*Sac*I and introduced into the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)* genomic locus in HKy639 selecting Ura^+^ integrants (HKy768, HKy769). As a control, a construct containing only *[rap1](http://www.yeastgenome.org/locus/S000005160/overview)∆C* (HK128, HK132) that truncated the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)* gene at codon 662 was engineered in a similar fashion, creating pHK71. This plasmid was sequence verified and integrated at the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)* genomic locus in HKy639 selecting Ura^+^ integrants (HKy754, HKy755).

Generation of *RIF1*, *XRS2*, and *TLC1* deletion strains {#s8}
---------------------------------------------------------

To generate the *[RIF1](http://www.yeastgenome.org/locus/S000000479/overview)* deletion, the *[LEU2](http://www.yeastgenome.org/locus/S000000523/overview)* cassette was amplified from pRS405 (OCC85, OCC86) ([@bib8]) and integrated into the *[RIF1](http://www.yeastgenome.org/locus/S000000479/overview)* locus of CVy245, yielding HKy639. Leu^+^ integrants were verified by PCR before tetrad analysis. A diploid yeast strain containing *[XRS2](http://www.yeastgenome.org/locus/S000002777/overview)/[xrs2](http://www.yeastgenome.org/locus/S000002777/overview)∆Ct* (yYM311), previously generated in our laboratory ([@bib42]), was transformed to delete the *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* locus using a PCR product containing the *[LEU2](http://www.yeastgenome.org/locus/S000000523/overview)* cassette from pRS405 (OCC122, OCC123) ([@bib8]) to generate JHUy912. The [Rap1](http://www.yeastgenome.org/locus/S000005160/overview)--[Rif2](http://www.yeastgenome.org/locus/S000004445/overview)~60~ fusion was introduced into these strains by transformation to replace the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)* locus as described above.

A deletion of *[TLC1](http://www.yeastgenome.org/locus/S000006657/overview)* was introduced into *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)/[rif2](http://www.yeastgenome.org/locus/S000004445/overview)∆*, *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)/[rap1](http://www.yeastgenome.org/locus/S000005160/overview)*::*([Rap1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[Rif2](http://www.yeastgenome.org/locus/S000004445/overview)~60~--[URA3](http://www.yeastgenome.org/locus/S000000747/overview))* (HKy551) by transformation of a PCR product from yeast strain YCC115 containing a *[tlc1](http://www.yeastgenome.org/locus/S000006657/overview)∆*::*[LEU2](http://www.yeastgenome.org/locus/S000000523/overview)* cassette (OCC168, OCC171) to generate two independent diploids HKy668 and HKy669. The Leu^+^ integrants were verified by PCR.

Southern analysis and telomere length measurement {#s9}
-------------------------------------------------

Strains for telomere length analysis were grown overnight at 30° in liquid medium yeast extract-peptone-dextrose (YPD). Five OD~600~ of cells were collected per sample and washed with water. Genomic DNA was prepared from each strain as follows: Cell pellets were ruptured by 8 min of vigorous shaking (Eppendorf mixer 5432) in equal volumes of 0.5 mm glass beads (Biospec Products), phenol-chloroform (50:50), and lysis buffer \[1% sodium dodecyl sulfate (SDS), 2% Triton X-100, 100 mM sodium chloride (NaCl), 10 mM Tris, pH 8.0, 1 mM ethylenediamine tetracetic acid (EDTA)\]. DNA was precipitated in ethanol and resuspended at 37° in TE (10 mM Tris, pH 8.0, 1 mM EDTA) and RNaseA (10 µg/ml). Samples were digested with *Xho*I and separated by electrophoresis on a 1% agarose gel in 1× TTE buffer (20× = 1.78 M Tris base, 0.57 M taurine, 0.01 M EDTA). On each gel, 250 ng of 2-log DNA ladder (NEB N3200) was included as a reference. After electrophoresis was complete, the gel was denatured for 30 min \[0.2 M sodium hydroxide (NaOH), 0.34M NaCl\] and neutralized (1.5 M NaCl, 0.5 M Tris, pH 7.0) for 30 min before vacuum transfer (Boekel Appligene vacuum blotter) at 50 mbar onto Amersham Hybond-N+ membrane (GE Healthcare) in 10× SSC (1.5 M NaCl, 0.17 M sodium citrate) for 1 hr. After UV-crosslinking (UV Stratalinker 2400, Stratagene), the membrane was prehybridized for 1--2 hr in Church buffer (0.5 M Tris, pH 7.2, 7% SDS, 1% bovine serum albumin, 1 mM EDTA) and hybridized with a radiolabeled subtelomeric Y′ fragment (750-bp fragment generated by PCR from yeast genomic DNA using primers YPrimeFWD and YPrimeREV) and radiolabeled 2-log DNA ladder probe. Hybridized nylon membranes were exposed to Storage Phosphor Screens (GE Healthcare) and scanned on a Storm 825 imager (GE Healthcare). The images were converted using Adobe Photoshop CS6 and adjusted for contrast using the curves feature within the software. In the represented Southern blots, the numbers on the *x*-axis indicate the sizes of the 2-log ladder in kilobases. The numbers on the *y*-axis represent the lane numbers in the agarose gel.

Western blot analysis {#s10}
---------------------

Yeast strains were grown at 30° in YPD until OD~600~ reached 0.4--0.6. Whole cell protein lysates were prepared by trichloroacetic acid (TCA) extraction as follows: three OD~600~ of cells were collected and resuspended in 10 ml of 10% TCA for 30 min. After centrifugation, the TCA-treated cells were resuspended in 1 ml 1 M HEPES buffer, pH 7.5 and transferred into a microcentrifuge tube. Cells were pelleted and resuspended in 50 µl 2× SDS-polyacrylamide gel electrophoresis (PAGE) sample buffer \[125 mM Tris, pH 6.8, 4% SDS, 20% glycerol, 0.2 M dithiothreitol (DTT), 0.012% bromophenol blue dye (BPB)\] then ruptured with an equal amount of 0.5 mm glass beads for 3 min on a high-speed vortex mixer. An additional 50 μl of 2× SDS-PAGE buffer was added to each sample, followed by 5 min at 100° and 15 sec of vigorous shaking. The samples were centrifuged for 10 min at top speed in a microcentrifuge and the supernatant was collected and stored at −20°.

Whole cell lysate (3 μl) was loaded per lane on a 10% TGX SDS-PAGE gel (Bio-Rad) along with molecular weight protein standards (Bio-Rad no. 161-0373) and resolved by electrophoresis. The proteins were transferred to 0.45 µm Immobilon-FL membrane (Millipore) according to recommended protocol (Bio-Rad). All Blue, Precision Plus protein standards (Bio-Rad no. 161-0373) were used as molecular weight markers. All transferred membranes were blocked in Odyssey blocking buffer (LI-COR) for 1 hr at room temperature (RT). The membranes were washed three times in 1× wash buffer (10 mM Tris, pH 8.0, 150 mM NaCl, 0.1% Triton X-100, 0.01% IGEPAL CA-630; Sigma) for 15 min, 5 min, and 5 min at RT. When using LI-COR detection, the final wash contained no detergents (1× TBS: 10 mM Tris, pH 8.0, 150 mM NaCl). The 13xMyc epitope was detected with a 1:10,000 dilution of anti-Myc 9E10 antibody (National Cell Culture Center, Minneapolis). Anti-actin (1:500 dilution of Anti-actin; Sigma A2066) and anti-PGK (1:10,000 dilution of anti-PGK; Invitrogen 459250) antibodies served as loading controls. The appropriate species IRDye secondary antibodies (LI-COR) were diluted at 1:15,000 in Odyssey blocking buffer and incubated for 2 hr at RT. Immunoblots were analyzed on an Odyssey infrared imaging system (LI-COR Biosystems) using the quantification software provided. The [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) protein levels of the samples were compared to the actin or the PGK loading control; this ratio in the wild type (WT) was set to 1 and the other samples were normalized to this value. The [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) protein level from two independent haploids was determined, and the average of these two values is reported in [Figure 1](#fig1){ref-type="fig"}.

![Summary of telomere length and protein expression in *rif2--NAAIRS* mutants. The telomere length of each of the *rif2--NAAIRS* mutants was categorized as wild-type (WT), medium, or long. For mutants with medium or long telomeres, the *rif2--NAAIRS* construct was tagged with the 13xMyc epitope and the relative level of Rif2 protein was measured by Western analysis. For each mutant, protein level in two independent haploids was measured and normalized to the loading control and to wild-type Rif2 protein levels (see *Materials and Methods*). Each mutant was characterized as having WT (\>70%), medium (50--70%), or low expression level (0--50%). Highlighted mutants indicate those with either WT or medium Rif2 expression level and telomeres longer than WT. *NAAIRS* mutants that had WT telomere length were not retested to examine protein levels. Representative examples of Southerns and Westerns for these mutants are shown in [Figure S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-4.pdf).](573fig1){#fig1}

The V5 epitope was detected with a 1:2000 dilution of anti-V5 antibody (Invitrogen no. 460705) for 1 hr at RT. Anti-mouse immunoglobin G horseradish peroxidase (IgG-HRP)-linked secondary antibody (Cell Signaling Technologies no. 7076) was diluted 1:10,000 in 5% milk (Bio-Rad), 0.05% Triton X-100, and incubated for 45 min at RT. SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Scientific no. 34095) was used to detect the chemiluminescent signal on an ImageQuant LAS4000 mini (GE Healthcare). Since the loading control comigrated with the V5-tagged [Rif2](http://www.yeastgenome.org/locus/S000004445/overview), the blots were stripped with Restore Western Blot Stripping Buffer for 25 min at room temperature (Thermo Scientific no. 21059), washed three times in 1× TBS as described above, and verified that no signal was present. After treating 30 min to 1 hr in Odyssey blocking buffer, the membranes were then incubated for 1 hr at RT with 1:10,000 of anti-PGK using the same IgG-HRP-secondary antibody as described. The [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) protein levels of the samples and loading controls were quantitated using ImageJ ([@bib50]) and normalized relative to WT levels.

Data availability {#s26}
-----------------

All strains and plasmids described here and in the [Supporting Information](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-11.pdf) are available upon request.

Results {#s11}
=======

Scanning mutagenesis of RIF2 {#s12}
----------------------------

To better understand the role of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) in telomere length maintenance, we scanned the entire coding region of *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)*, substituting every 6 contiguous codons with a sequence encoding NAAIRS ([@bib38]), generating a set of 66 *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)--NAAIRS* mutants. The mutations were named for the first codon where the substitution begins. For example, NAAIRS2 substitutes codons 2--7, and NAAIRS8 substitutes codons 8--13. Each mutant was integrated into the yeast genome at the *[URA3](http://www.yeastgenome.org/locus/S000000747/overview)* locus in a *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)/[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* heterozygous diploid and verified by sequencing. Wild-type *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* integrated at *[URA3](http://www.yeastgenome.org/locus/S000000747/overview)*, as a control, was able to complement a *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* (data not shown). Telomere length was examined in *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ*::*kanMX4 [ura3](http://www.yeastgenome.org/locus/S000000747/overview)-1*::*rif2NAAIRS-[URA3](http://www.yeastgenome.org/locus/S000000747/overview)* haploid segregants by Southern blot and classified as wild type, long (similar to *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ*), or medium (between *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* and wild type). There were a number of regions in *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* where *NAAIRS* mutations resulted in a long telomere phenotype similar to *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* ([Figure 1](#fig1){ref-type="fig"} and [Figure S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-4.pdf)).

To determine whether the mutant proteins were expressed at wild-type levels, we tagged each of the mutants that showed long telomeres with a 13xMyc tag and quantified [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) protein levels by Western analysis. As a control, we tagged a wild-type copy of *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* integrated at the *[URA3](http://www.yeastgenome.org/locus/S000000747/overview)* locus and showed the 13xMyc tag did not affect telomere length ([Figure S2A](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-8.pdf)). A number of the NAAIRS substitutions resulted in significantly reduced protein expression; for example, the mutations NAAIRS212 and NAAIRS338 ([Figure S1A](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-4.pdf)), disrupted protein stability, suggesting the long telomeres in these mutants were likely due to low [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) levels. However, there was a distinct subset of mutants in which wild-type or near wild-type protein levels were present and yet the NAAIRS substitution resulted in longer than wild-type length telomeres ([Figure 1](#fig1){ref-type="fig"}). Strikingly, 7 of 11 of the long or medium length mutants that expressed at least 50% protein levels were in the N-terminal domain of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview). We thus focused our attention on this N-terminal region.

While this work was underway, the Thoma lab reported the crystal structure of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) protein and [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) complexed with the C-terminal domain of [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) ([@bib51]). [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) contains a large central AAA+ domain with Walker A and Walker B motifs. The crystal structure revealed a C-terminal domain in [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) that interacts with [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) ([Figure 2A](#fig2){ref-type="fig"}). The N-terminal domain of the [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) protein from amino acid (aa) 1--60 was mostly unstructured but contained a short helix from T37-K48 called the **R**ap1 **B**inding **M**otif (RBM). A peptide spanning [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) residues 30--49 bound to the [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) C-terminal domain in solution. This peptide has two residues, L42 and L44, which have crystal contacts with the [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) C-terminal domain, while residues 49--60 were unstructured ([@bib51]). As mentioned above, the block of NAAIRS mutations that affected protein function (NAAIRS2--NAAIRS44) was located in this unstructured N-terminal domain of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview).

![Point mutants in *RIF2* disrupt protein function. (A) The domain structure of Rif2 protein is shown. The C-terminal region binds Rap1. There is an AAA+ domain that contains Walker A and B motifs (designated WA and WB). The N-terminal domain is not well structured but contains a short helix (RBM) that interacts with Rap1. The regions in white have no known structure. (B) The alignment of residues in the Rif2 N-terminal region from five *Saccharomyces* species is shown. Identical residues are highlighted in blue, those residues with strong similarity are in dark gray, and those with weak similarity in light gray. (C) Southern blot analysis of telomeres from *rif2--NAAIRS8* and the six individual mutations within the *rif2--NAAIRS8* mutant. The size markers on the side represent kilobases. Two independent haploid transformants for each single point mutant are shown.](573fig2){#fig2}

N-terminal rif2 point mutants have long telomeres {#s13}
-------------------------------------------------

The N-terminal region of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) is highly conserved among *Saccharomyces* ([Figure 2B](#fig2){ref-type="fig"}). To probe this region more closely, we substituted each individual residue from aa 2--37 with alanine (or a different residue if alanine was the wild-type residue). These point mutants were tagged with a V5 epitope and integrated at the *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* genomic locus in haploid cells. The telomere length of two independent transformants of each mutant was compared to four controls: wild type, *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)*, *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ*, and the original NAAIRS mutant haploid strain ([Figure 2C](#fig2){ref-type="fig"} and [Figure S3](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-1.pdf)). Control experiments showed that the V5 tag did not affect telomere length at the wild-type *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* locus ([Figure S2](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-8.pdf)B). If discordant results were obtained with two independent transformants, additional transformants were analyzed to determine the effect of that mutant.

Mutations in six residues in the N-terminal region resulted in telomere elongation: D5, F8, I11, R12, R13, and D29 ([Figure 2C](#fig2){ref-type="fig"} and [Figure S2C](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-8.pdf), also see [Figure S3](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-1.pdf)). Mutants in F8, I11, R12, and R13 were expressed at or just above wild-type levels, while D5 and D29 were slightly reduced ([Figure S2D](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-8.pdf)). All of these residues fall within the unstructured region in the crystal structure ([@bib51]). Remarkably, the single amino acid change F8A showed significant telomere lengthening comparable to both the six-codon change in *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)--NAAIRS8* and *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* ([Figure 2C](#fig2){ref-type="fig"}), suggesting this is a key residue in [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) that is critical for telomere length regulation. In addition to residues with a major effect, there were also residues that had smaller effects. For some NAAIRS mutants, such as *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)--NAAIRS14* and *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)--NAAIRS20*, none of the single mutants affected telomere length, however when all six codons were mutated in combination, telomere lengthening was observed ([Figure S3](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-1.pdf)). These results are consistent with this region being a binding site for some protein, in which docking of the F8 residue is the most critical, and neighboring residues contribute to the interaction.

The N-terminal domain of Rif2 mediates telomere length regulation {#s14}
-----------------------------------------------------------------

Because the mutants in the N terminus of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) mimic loss of function of the [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) protein, we next asked whether this N-terminal domain would function alone if tethered at the telomere. We generated a fusion gene encoding the N-terminal 60 codons of *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* fused to the C terminus of *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*. We will refer to this construct as *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~60~* and to the resulting fusion protein as [Rap1](http://www.yeastgenome.org/locus/S000005160/overview)--[Rif2](http://www.yeastgenome.org/locus/S000004445/overview)~60~ ([Figure 3A](#fig3){ref-type="fig"}). We chose the N-terminal 60 aa of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) because in the crystal structure the well-structured protein begins at residue 61. To promote flexibility of the fusion domain, we added a glycine linker sequence between [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) and the [Rif2](http://www.yeastgenome.org/locus/S000004445/overview)~60~ N-terminal domain. The *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~60~* construct was transformed into a *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)/[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* heterozygous diploid and integrated at the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)* genomic locus. *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)/[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ*, *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*/*[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~60~* double heterozygotes were sporulated and telomere lengths were examined in two independent spores as well as in the diploids. Remarkably, the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~60~* construct fully suppressed the telomere lengthening in a *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* mutant ([Figure 3B](#fig3){ref-type="fig"}, lanes 4 and 5). Moreover, this domain dominantly shortened telomeres since telomeres were shorter in the heterozygous diploid *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)*/*[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* containing the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~60~* construct than in the parental diploid ([Figure 3B](#fig3){ref-type="fig"}, lanes 2 and 3). This shortening effect was also observed in haploid cells. Wild-type cells expressing the fusion had telomeres shorter than wild-type cells without the fusion ([Figure 3B](#fig3){ref-type="fig"}, lanes 6 and 7). This gain-of-function effect may result from alteration of the regulated cell cycle dissociation of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) from the telomere ([@bib54]), as discussed below. The suppression of the *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* phenotype by the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~60~* construct suggests that tethering this functional domain of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) at the telomere blocks excessive telomere elongation.

![Rap1--Rif2~60~ fusion protein blocks telomere elongation. (A) Schematic of Rap1--Rif2~60~ fusion protein. The full-length *RAP1* coding region was fused in frame to a glycine 10 linker followed by the first 60 codons of *RIF2*. (B) *rif2Δ* mutants expressing the *RAP1*--*RIF2~60~* construct. The genotype of the strain is indicated in each lane and the presence or absence of the fusion protein is shown with a + sign in each lane. The parental diploid was transformed with the fusion construct to yield the heterozygous diploid (Het. diploid) and was dissected to generate the haploid segregants. (C) Expression of *RAP1*--*RIF2~60~* construct in *rif1Δ* mutants and *rif1Δ rif2Δ* mutants. The genotype of the strain is indicated in each lane and the presence or absence of the fusion protein is show with a + sign. The size markers on the side represent kilobases.](573fig3){#fig3}

[Rif1](http://www.yeastgenome.org/locus/S000000479/overview) and [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) act through different pathways to limit telomere extension ([@bib62]). To test whether the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)--[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~60~* construct would also block *[rif1](http://www.yeastgenome.org/locus/S000000479/overview)Δ* telomere elongation, we generated a triple heterozygous diploid: *[RIF1](http://www.yeastgenome.org/locus/S000000479/overview)/[rif1](http://www.yeastgenome.org/locus/S000000479/overview)Δ*, *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)/[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ*, *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*/*[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~60~*~.~ Telomere length was measured in two independent haploids of each genotype ([Figure 3C](#fig3){ref-type="fig"}). The [Rap1](http://www.yeastgenome.org/locus/S000005160/overview)--[Rif2](http://www.yeastgenome.org/locus/S000004445/overview)~60~ fusion protein fully suppressed the long telomeres in both *[rif1](http://www.yeastgenome.org/locus/S000000479/overview)Δ* and *[rif1](http://www.yeastgenome.org/locus/S000000479/overview)Δ [rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* mutants.

We noted that there was a slight difference in telomere length in *[rif1](http://www.yeastgenome.org/locus/S000000479/overview)Δ [rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* cells compared to *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* cells expressing the fusion construct ([Figure 3C](#fig3){ref-type="fig"}, compare lanes 10 and 11 to lanes 18 and 19). To test whether this difference was due to insufficient cell divisions needed to reach steady state, we passaged cells four times in subcultures. The telomere length of each mutant expressing the fusion protein was stable over the successive passages ([Figure S4](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-6.pdf)). The slight difference in final telomere length in *[rif1](http://www.yeastgenome.org/locus/S000000479/overview)Δ* or *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* mutants expressing the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~60~* construct might reflect the fact that [Rif1](http://www.yeastgenome.org/locus/S000000479/overview) affects telomere length through a different pathway than [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) ([@bib62]).

To determine whether telomere shortening in cells expressing the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~60~* construct was working through the telomerase pathway we deleted the telomerase RNA component, *[TLC1](http://www.yeastgenome.org/locus/S000006657/overview)*, in a *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)*/*[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ*, *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)/RAP1-RIF2~60~* diploid. Telomere elongation in *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* mutants was blocked by the loss of telomerase ([Figure S5](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-12.pdf)), as shown previously ([@bib57]). Expression of the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)--[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~60~* fusion in *[tlc1](http://www.yeastgenome.org/locus/S000006657/overview)Δ* had little effect on telomere length, while *[tlc1](http://www.yeastgenome.org/locus/S000006657/overview)Δ [rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* cells not expressing the fusion construct had slightly longer telomeres than those expressing the construct ([Figure S5A](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-12.pdf), compare lanes 10 and 11 to lanes 12 and 13). While this slight difference could be due to effects of the fusion protein on other telomere maintenance pathways, we suspect it is due to increased telomere recombination in the *[tlc1](http://www.yeastgenome.org/locus/S000006657/overview)Δ [rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* cells. The loss of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) in a telomerase mutant has previously been shown to promote recombination and accelerate survivor formation ([@bib57]; [@bib11]; [@bib2]; [@bib30]). We found that the rapid appearance of survivors in *[tlc1](http://www.yeastgenome.org/locus/S000006657/overview)Δ [rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* cells led to slightly longer bulk telomere bands than *[tlc1](http://www.yeastgenome.org/locus/S000006657/overview)Δ* ([Figure S5B](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-12.pdf), compare lanes 4 and 5 to lanes 6 and 7). Expression of the fusion construct may delay telomere recombination. Taken together, the telomere shortening caused by the [Rap1](http://www.yeastgenome.org/locus/S000005160/overview)--[Rif2](http://www.yeastgenome.org/locus/S000004445/overview)~60~ fusion protein and the requirement for telomerase indicate that this small domain of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) can block telomere overelongation by telomerase in both *[rif1](http://www.yeastgenome.org/locus/S000000479/overview)Δ* and *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* mutants. We will refer to this functional N-terminal domain as the BAT domain for **B**locks **A**ddition of **T**elomeres.

The function BAT domain does not require interaction with the RAP1 C-terminal domain {#s15}
------------------------------------------------------------------------------------

The N-terminal 60 amino acids of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) include a small helical domain termed RBM between positions T37 and K48 that makes crystal contacts with the C-terminal domain of [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) ([@bib51]). To determine whether the binding to the [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) C terminus is required for the function of the BAT domain we took two approaches: first, we removed the C terminus of [Rap1](http://www.yeastgenome.org/locus/S000005160/overview), and second, we created a fusion protein with a shorter version of the BAT domain that lacks the RBM region ([Figure 4A](#fig4){ref-type="fig"}).

![The C-terminal domain of Rap1 is not required for BAT domain function. (A) Schematic of three fusion protein constructs. (B) *rif1Δ*, *rif2Δ*, and *rif1Δ rif2Δ* double mutants expressing *rap1ΔC*--*RIF2~60~* construct were analyzed by Southern blot. The genotype of the strain is indicated above each lane and the presence or absence of the fusion construct is shown with a + sign in each lane. (C) *rif2Δ* mutants expressing the fusion construct with a shortened Rif2 N terminus, *RAP1*--*RIF2~36~*. The genotype of the strain is indicated above each lane and the presence or absence of either the *RAP1*--*RIF2~36~* construct or *RAP1*--*RIF2~60~* construct is shown with a + sign. (D) *rif1Δ* and *rif1Δ rif2Δ* double mutants expressing the shortened Rif2 N terminus, *RAP1*--*RIF2~36~*. The genotype of the strain is indicated above each lane and the presence or absence of either the *RAP1*--*RIF2~36~* construct or the *RAP1*--*RIF2~60~* construct is shown with a + sign. The size markers on the side represent kilobases.](573fig4){#fig4}

We generated a new fusion construct (termed [rap1](http://www.yeastgenome.org/locus/S000005160/overview)*ΔC*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~60~*) in which the [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) C terminus is truncated at amino acid 662 with the [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) BAT domain fused to the [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) DNA binding domain. The expression of the [rap1](http://www.yeastgenome.org/locus/S000005160/overview)*ΔC*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~60~* fusion completely suppressed the long telomere phenotype in *[rif1](http://www.yeastgenome.org/locus/S000000479/overview)Δ*, *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ*, and *[rif1](http://www.yeastgenome.org/locus/S000000479/overview)Δ [rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* mutants ([Figure 4B](#fig4){ref-type="fig"}). This result indicates the BAT domain does not need the [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) C terminus to block telomere elongation. As a control, in the same strain, we generated a [Rap1](http://www.yeastgenome.org/locus/S000005160/overview)ΔC-truncated at amino acid 662 that lacks [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) BAT domain. As expected, expression of the [Rap1](http://www.yeastgenome.org/locus/S000005160/overview)ΔC-truncation showed long telomeres and did not rescue telomere length in *[rif1](http://www.yeastgenome.org/locus/S000000479/overview)Δ*, *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ*, or *[rif1](http://www.yeastgenome.org/locus/S000000479/overview)Δ [rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* ([Figure S6](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-5.pdf)).

Next we examined a fusion with a shortened BAT domain, [rap1](http://www.yeastgenome.org/locus/S000005160/overview)*ΔC--[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~36~*, which lacks the RBM residues ([Figure 2](#fig2){ref-type="fig"}). Expression of [Rap1](http://www.yeastgenome.org/locus/S000005160/overview)--[Rif2](http://www.yeastgenome.org/locus/S000004445/overview)~36~ fully blocked telomere elongation in *[rif1](http://www.yeastgenome.org/locus/S000000479/overview)Δ*, *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ*, and *[rif1](http://www.yeastgenome.org/locus/S000000479/overview)Δ [rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* mutants ([Figure 4, C and D](#fig4){ref-type="fig"}). While this *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~36~* construct restored wild-type telomere length, it did not cause shortening below wild-type length like the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~60~* construct ([Figure 4, C and D](#fig4){ref-type="fig"}). This lesser degree of telomere shortening by the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~36~* compared to the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~60~* could be due to a slightly reduced accessibility or flexibility of this shorter domain. The lack of requirement for the [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) C-terminal domain, together with the ability of the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~36~* to fully restore wild-type telomere length, suggest that the BAT domain of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) does not require the presence of the [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) C terminus to affect telomere shortening.

XRS2 C terminus does not mediate the function of the Rif2 BAT domain {#s16}
--------------------------------------------------------------------

Recent studies have suggested that [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) binds to the C-terminal region of [Xrs2](http://www.yeastgenome.org/locus/S000002777/overview) and that this blocks [Tel1](http://www.yeastgenome.org/locus/S000000184/overview) telomere association, thereby limiting telomere elongation ([@bib28]). To determine whether the C-terminal domain of *[XRS2](http://www.yeastgenome.org/locus/S000002777/overview)* is required for the ability of the BAT domain to limit telomere length, we introduced the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~60~* construct into a doubly heterozygous strain *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)Δ/[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ [XRS2](http://www.yeastgenome.org/locus/S000002777/overview)/[xrs2](http://www.yeastgenome.org/locus/S000002777/overview)ΔCt* expressing an [Xrs2](http://www.yeastgenome.org/locus/S000002777/overview) C-terminal truncation protein that fails to bind [Tel1](http://www.yeastgenome.org/locus/S000000184/overview) ([@bib42]) and examined telomeres in the single and double mutant haploid segregants. Expression of the [Rap1](http://www.yeastgenome.org/locus/S000005160/overview)--[Rif2](http://www.yeastgenome.org/locus/S000004445/overview)~60~ fusion protein resulted in significant shortening in the *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ [xrs2](http://www.yeastgenome.org/locus/S000002777/overview)∆Ct* cells ([Figure 5](#fig5){ref-type="fig"}, lanes 16 and 17). These results suggest that the [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) BAT domain can regulate telomere length independent of the [Xrs2](http://www.yeastgenome.org/locus/S000002777/overview) C-terminal domain.

![Xrs2 C terminus is not required for the Rif2 BAT domain to shorten telomeres. Southern blot telomere analysis of *xrs2Δ*Ct and *rif2Δ xrs2Δ*Ct cells expressing *RAP1*--*RIF2~60~* construct. The genotype of the strain is indicated above each lane and the presence or absence of the *RAP1*--*RIF2~60~* construct is shown with a + sign. The size markers on the side represent kilobases.](573fig5){#fig5}

Mutations at F8 abolish the shortening effect of the Rap1--Rif2~60~ fusion protein {#s17}
----------------------------------------------------------------------------------

In the NAAIRS scanning mutagenesis experiments, we identified the F8 residue as playing a major role in [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) function. To determine if this amino acid was also important in the effect of the [Rap1](http://www.yeastgenome.org/locus/S000005160/overview)--[Rif2](http://www.yeastgenome.org/locus/S000004445/overview)~60~ protein, we made a fusion construct containing this F8A substitution. When this mutant *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[rif2](http://www.yeastgenome.org/locus/S000004445/overview)~60~ \[F8A\]* fusion construct was expressed in a *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* background, telomere shortening did not occur ([Figure 6A](#fig6){ref-type="fig"}, lanes 14 and 15), indicating the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[rif2](http://www.yeastgenome.org/locus/S000004445/overview)~60~ \[F8A\]* mutation renders the BAT domain nonfunctional. Curiously, long telomeres were seen when the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[rif2](http://www.yeastgenome.org/locus/S000004445/overview)~60~ \[F8A\]* fusion construct was expressed in wild-type haploids ([Figure 6A](#fig6){ref-type="fig"}, lanes 9 and 10), suggesting that tethering the mutant BAT domain to [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) dominantly interferes with normal length regulation. Since this construct is the only copy of *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)* in the cell, all of the telomeres should be bound by the [Rap1](http://www.yeastgenome.org/locus/S000005160/overview)--[Rif2](http://www.yeastgenome.org/locus/S000004445/overview)~60~ \[F8A\] protein and thus may interfere with the function of the wild-type [Rif2](http://www.yeastgenome.org/locus/S000004445/overview).

![Aromatic residue at position 8 is important for Rif2 BAT domain function. (A) Southern blot telomere analysis of WT and *rif2Δ* cells expressing either *RAP1*--*RIF2~60~* or *RAP1*--*rif2~60~ \[F8A\]* mutant fusion construct. The genotype of the strain is indicated above each lane and the presence or absence of the given fusion protein is shown with a + sign. (B) Southern blot telomere analysis of *RIF1 RIF2*, *rif2Δ*, *rif1Δ*, and *rif1Δ rif2Δ* mutants expressing *RAP1*--*rif2~60~ \[F8A\]* fusion or no fusion. The genotype of the strain is indicated above each lane and the presence or absence of the *RAP1*--*rif2~60~ \[F8A\]* is shown with a + sign. The parental diploid was transformed with the fusion construct to yield the heterozygous diploid (Het. diploid) and dissected for the haploid segregants. (C) Southern blot telomere analysis of WT, *rif2Δ*, *rif1Δ*, and *rif1Δ rif2Δ* mutants expressing *RAP1*--*rif2~60~ \[F8W\]* fusion. The genotype of the strain is indicated above each lane and the presence of the *RAP1*--*rif2~60~ \[F8W\]* is shown with a + sign. (D) Southern blot telomere analysis of WT, *rif2Δ*, *rif1Δ*, and *rif1Δ rif2Δ* mutants expressing *RAP1*--*rif2~60~ \[F8Y\]* fusion. The genotype of the strain is indicated above each lane and the presence of *RAP1*--*rif2~60~ \[F8Y\]* fusion protein is shown with a + sign. The size markers on the side represent kilobases.](573fig6){#fig6}

Aromatic amino acid tryptophan can mimic phenylalanine at F8 {#s18}
------------------------------------------------------------

The functional importance of the *F8A* mutation in both the *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* gene and in the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[rif2](http://www.yeastgenome.org/locus/S000004445/overview)~60~ \[F8A\]* fusion suggests this region may be a protein--protein interaction site. To test whether aromatic phenylalanine may be specifically recognized, we substituted this amino acid with either of the aromatic amino acids, tryptophan or tyrosine. Remarkably, the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[rif2](http://www.yeastgenome.org/locus/S000004445/overview)~60~ \[F8W\]* restored telomere shortening in *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ*, *[rif1](http://www.yeastgenome.org/locus/S000000479/overview)Δ*, and *[rif1](http://www.yeastgenome.org/locus/S000000479/overview)Δ [rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* ([Figure 6, C and D](#fig6){ref-type="fig"}), indicating an aromatic amino acid can at least partially restore the function of the BAT domain. The *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*rif2~60~ \[F8Y\]* mutation more closely resembled the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*rif2~60~ \[F8A\]* mutant, suggesting this residue may interfere with function. These experiments support the model that the F8 aromatic residue in the BAT domain is an important binding determinant for an as yet unknown protein that limits telomere elongation.

Discussion {#s19}
==========

To probe the mechanism of telomere length regulation, we carried out scanning mutagenesis of *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* and identified an N-terminal domain that is essential for blocking telomere elongation. The substitution of a single amino acid, F8A, within the BAT domain mimicked the long telomeres in a *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* mutant. Further, tethering this 60 amino acid domain to [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) fully blocked telomere elongation. The F8 residue was essential for blocking excess elongation, as the *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*--*[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)~60~ \[F8A\]* fusion did not block telomere elongation in *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* mutants. These results imply the BAT domain regulates telomere length by a similar mechanism in the context of either full-length *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* or as an isolated domain tethered to *[RAP1](http://www.yeastgenome.org/locus/S000005160/overview)*.

The Rap1/Rif1/Rif2 scaffold is not essential to block telomere elongation {#s20}
-------------------------------------------------------------------------

Our results suggest the recently proposed molecular Velcro model for telomere length regulation may be incomplete. In this Velcro model, [Rif1](http://www.yeastgenome.org/locus/S000000479/overview), [Rif2](http://www.yeastgenome.org/locus/S000004445/overview), and [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) are suggested to generate an interlocking molecular scaffold that limits telomerase access to the telomere ([@bib51]). Specifically [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) is proposed to contribute to the scaffold by bridging two [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) molecules, binding one through the RBM and the other through the AAA+ domain. [Rif1](http://www.yeastgenome.org/locus/S000000479/overview) is likewise proposed to make contact with two [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) molecules to further support the scaffold. While our data do not address whether this scaffold forms in wild-type cells, they do suggest that such a structure is not required to block the elongation of telomeres by telomerase.

BAT domain as a functional protein-binding site {#s21}
-----------------------------------------------

The modular nature of the BAT domain, and the critical F8 residue, suggests that this region of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) may be a protein--protein interaction domain. The high conservation of the BAT domain in *Saccharomyces* ([Figure 2B](#fig2){ref-type="fig"}) further supports a role in protein binding. We propose that the F8 residue is the critical determinant in a binding site and that surrounding amino acids also contribute to important protein contacts. When residues near F8 were singly mutated, there was less effect on telomere length than when they were mutated together as groups of six residues ([Figure 2](#fig2){ref-type="fig"}). This additive effect was also seen in the NAAIRS2, NAAIRS14, and NAAIRS20 mutants, in which the single amino acid changes did not have as strong an effect as the group of 6 mutations ([Figure S3](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-1.pdf)). This finding suggests that there is a protein interaction interface over a region surrounding F8, and this aromatic residue is the key player in a protein interaction. The BAT domain may recruit an unknown protein as described below or it may interact directly with known proteins such as [Cdc13](http://www.yeastgenome.org/locus/S000002379/overview), [Stn1](http://www.yeastgenome.org/locus/S000002489/overview), [Ten1](http://www.yeastgenome.org/locus/S000004000/overview), or telomerase to block elongation. We ruled out the [Xrs2](http://www.yeastgenome.org/locus/S000002777/overview) C-terminal domain as playing a major role ([@bib28]) since [Xrs2](http://www.yeastgenome.org/locus/S000002777/overview) C-terminal truncations still showed telomere shortening with the [Rap1](http://www.yeastgenome.org/locus/S000005160/overview)--[Rif2](http://www.yeastgenome.org/locus/S000004445/overview)~60~ fusion protein.

The Rap1--Rif2~60~ fusion causes telomere shortening {#s22}
----------------------------------------------------

The dominant effect of the [Rap1](http://www.yeastgenome.org/locus/S000005160/overview)--[Rif2](http://www.yeastgenome.org/locus/S000004445/overview)~60~ fusion in diploid cells and its ability to shorten telomeres in haploids may be due to altered cell cycle regulation, altered affinity, loss of end protection, or a combination of these factors. The cell cycle-regulated associations of [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) and [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) with the telomere differ; [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) telomere association increases while [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) decreases in late S-phase ([@bib54]). It may be this dissociation of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) in late S-phase that allows telomere elongation. In our experiment, by tethering the functional BAT domain of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) to [Rap1](http://www.yeastgenome.org/locus/S000005160/overview), this dissociation at late S-phase cannot occur and thus telomere elongation may be more efficiently blocked.

The [Rap1](http://www.yeastgenome.org/locus/S000005160/overview)--[Rif2](http://www.yeastgenome.org/locus/S000004445/overview)~60~ fusion also shortened telomeres in a *[rif1](http://www.yeastgenome.org/locus/S000000479/overview)Δ* mutant. [Rif1](http://www.yeastgenome.org/locus/S000000479/overview) regulates telomere elongation through a mechanism independent of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview), thus the ability of the [Rap1](http://www.yeastgenome.org/locus/S000005160/overview)--[Rif2](http://www.yeastgenome.org/locus/S000004445/overview)~60~ to block telomerase elongation after the loss of [Rif1](http://www.yeastgenome.org/locus/S000000479/overview) suggests that the mechanism by which BAT blocks telomere elongation is not pathway specific. Experiments by [@bib35] also showed that both the *[rif1](http://www.yeastgenome.org/locus/S000000479/overview)Δ* and *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* long telomere phenotypes could be counteracted by overexpression of a [Rap1](http://www.yeastgenome.org/locus/S000005160/overview)--PDZ fusion protein that allows multimerization of [Rap1](http://www.yeastgenome.org/locus/S000005160/overview). This further suggests that while [Rif1](http://www.yeastgenome.org/locus/S000000479/overview) and [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) may normally act through different pathways, strengthening just one of those pathways may be sufficient to block telomere over elongation.

Putting the pieces together: a model for Rif2 BAT domain function {#s23}
-----------------------------------------------------------------

Our data suggest that the BAT domain of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) is a protein-binding domain that limits telomere elongation by telomerase. This domain may directly block telomere elongation or may recruit another protein that binds to the F8 residue in the BAT domain and blocks telomere elongation as depicted in [Figure 7A](#fig7){ref-type="fig"}. When [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) is missing, telomerase can overextend the telomeres ([Figure 7B](#fig7){ref-type="fig"}). However tethering the BAT domain directly to [Rap1](http://www.yeastgenome.org/locus/S000005160/overview) restores and even strengthens the block to telomerase ([Figure 7C](#fig7){ref-type="fig"}). The specific mechanism by which the BAT domain blocks telomerase elongation is not clear; it might directly interfere with the catalytic subunit [Est2](http://www.yeastgenome.org/locus/S000004310/overview) recruitment or it could affect elongation indirectly by altering telomere processing or C-strand synthesis. In addition to blocking telomerase, [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) plays a role in end protection. [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) blocks telomere recombination ([@bib57]), thereby delaying survivors ([@bib11]; [@bib2]; [@bib30]). [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) also protects telomeres from fusion ([@bib16]) and from nuclease processing ([@bib6]). The increased rate of telomere sequence turnover in *[rif2](http://www.yeastgenome.org/locus/S000004445/overview)Δ* mutants ([@bib34]) likely reflects the combined effects of increased telomere degradation, elongation, and recombination. It is not yet clear whether the functions of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) in end protection and in blocking telomerase elongation are separable or are the result of one mechanism. Our data support the role of [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) in blocking telomere recombination in telomerase mutants ([Figure S5](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1/genetics.115.177899-12.pdf)) and suggest that the BAT domain plays a role in this function.

![Model for separation of function of Rif2 and the BAT domain. In *RIF2* cells, the Rap1 protein, shown in green, binds to the telomeric double-stranded DNA and the C-terminal domain (dark green) recruits Rif1 (not shown for simplicity) and Rif2 (purple). Rif2 binds the Rap1 C-terminal domain and blocks nuclease activity and telomerase elongation. The N-terminal BAT domain of Rif2 (dark purple) contains a critical phenylalanine residue. The F8 residue in the BAT domain serves as a protein recognition motif for a critical protein (Prot. X) that limits telomerase elongation of the telomere. (B) In *rif2Δ* telomerase elongation is not blocked by Rif2. (C) When the BAT domain is fused directly to the Rap1 C-terminal region in the *RAP1*--*RIF2~60~* fusion construct, even in a *rif2Δ* mutant, there is strong blocking of telomerase.](573fig7){#fig7}

Telomere length regulation throughout evolution {#s24}
-----------------------------------------------

The negative regulation of telomere elongation in length homeostasis is conserved throughout evolution. While [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) protein sequence is not conserved from yeast to humans, the loss of telomere binding proteins leads to telomere elongation in mammals as well ([@bib48]). [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) in *S. cerevisiae* is a paralog of the conserved [Orc4](http://www.yeastgenome.org/locus/S000006366/overview) protein ([@bib10]). Analysis of synteny indicates that [Rif2](http://www.yeastgenome.org/locus/S000004445/overview) was generated by divergence after a whole genome duplication that occurred early in the *Saccharomyces* lineage ([@bib3]). Interestingly, the sequence conservation of *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* and *[ORC4](http://www.yeastgenome.org/locus/S000006366/overview)* ([@bib44]) does not include the BAT domain, suggesting *[RIF2](http://www.yeastgenome.org/locus/S000004445/overview)* acquired this regulatory module after the duplication and divergence from *[ORC4](http://www.yeastgenome.org/locus/S000006366/overview)*. This functional BAT domain, which limits telomere elongation, may be a conserved feature of telomere length regulation; however it may be attached to different telomere proteins in different organisms. A regulatory motif with similar function to the BAT domain may be present on other proteins and may contribute to conservation of the telomere length equilibrium mechanism across species.

 {#s25}

Supplementary Material
======================

###### Supporting Information

We thank Brendan Cormack and Rebecca Keener for critical reading of the manuscript. This work was supported by National Institutes of Health 5R01GM043080 to C.W.G. and by support to the Johns Hopkins Telomere Center.

Communicating editor: N. Hollingsworth

Supporting information is available online at [www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.115.177899/-/DC1).

[^1]: These authors contributed equally to this work.

[^2]: Present address: Program in Molecular Biophysics, Johns Hopkins University School of Medicine, Baltimore, MD 21205.

[^3]: Present address: National Institutes of Health, Office of Science Policy, Bethesda, MD 20817.
